Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-08-07, Stock:JNJ, The news for the past five days is as follows:
2018-07-31: NEWS1: U.S. insurers grilled on exposure to $4.7 billion J&J talc verdict.NEWS2: U.S. insurers grilled on exposure to $4.7 billion J&J talc verdict.NEWS3: A Look at Dentsply Sirona’s Expected Bottom Line in Q2 2018.NEWS4: Why Editas Medicine Stock Fell in July.NEWS5: Pfizer Beat Wall Street Analyst Estimates for Q2 2018 Earnings.NEWS6: Pfizer CEO expects Trump to eliminate drug rebates.NEWS7: What to Expect for DaVita’s Q2 2018 Earnings.NEWS8: Pfizer (PFE) Beats on Q2 Earnings & Sales, Ups Profit View.NEWS9: Pfizer (PFE) Beats on Q2 Earnings & Sales, Ups Profit View.
2018-08-01: NEWS1: Geron (GERN) Q2 Loss In Line, Revenues Up Y/Y, Shares Down.NEWS2: Geron (GERN) Q2 Loss In Line, Revenues Up Y/Y, Shares Down.NEWS3: Geron (GERN) Q2 Loss In Line, Revenues Up Y/Y, Shares Down.NEWS4: Why The 'Heat Wave' For U.S. Pharma Could Continue This Month.NEWS5: NYSE trader: American wealth and stock earnings are at record highs, so I can only be bullish.NEWS6: Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for August 02, 2018.NEWS7: Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for August 02, 2018.NEWS8: U.S. insurers grilled on exposure to $4.7 billion J&J talc verdict.
2018-08-02: NEWS1: Missouri governments sue drug companies over opioid epidemic.NEWS2: Theravance Biopharma (TBPH) Q2 Loss Narrows, Shares Up.NEWS3: Theravance Biopharma (TBPH) Q2 Loss Narrows, Shares Up.NEWS4: WHO sees complex vaccine and security questions in Ebola response.NEWS5: Theravance Biopharma (TBPH) Q2 Loss Narrows, Shares Up.NEWS6: Health Care Select Sector SPDR Fund Experiences Big Inflow.NEWS7: Health Care Select Sector SPDR Fund Experiences Big Inflow.NEWS8: Eli Lilly’s Neuroscience Products Sales Dropped in Q2 2018.NEWS9: Cosmetics avoided strict regulation for over a century. Rising health concerns has FDA inquiring..NEWS10: Better Buy: Johnson & Johnson vs. Pfizer.NEWS11: Better Buy: Johnson & Johnson vs. Pfizer.NEWS12: Better Buy: Johnson & Johnson vs. Pfizer.
2018-08-03: NEWS1: Aduro (ADRO) Q2 Loss Narrower Than Expected, Revenues Miss.NEWS2: Aduro (ADRO) Q2 Loss Narrower Than Expected, Revenues Miss.NEWS3: TESARO (TSRO) Misses Earnings and Revenue Estimates in Q2.NEWS4: TESARO (TSRO) Misses Earnings and Revenue Estimates in Q2.NEWS5: Eli Lilly’s Q2 2018 Earnings: New Products.
2018-08-06: NEWS1: Daabon Strikes Deal With Avicanna, Becoming The Largest Agro Company To Enter The Cannabis Industry.NEWS2: 3 Reasons Geron Corporation Stock Could Be a Big Winner.NEWS3: 3 Reasons Geron Corporation Stock Could Be a Big Winner.NEWS4: 3 Reasons Geron Corporation Stock Could Be a Big Winner.NEWS5: Pacira (PCRX) Q2 Earnings and Revenues Surpass Estimates.NEWS6: Pacira (PCRX) Q2 Earnings and Revenues Surpass Estimates.NEWS7: What Analysts Recommend for Haemonetics.NEWS8: Tesaro: Lower Fiscal 2018 Guidance, Share Price Fell on August 3.NEWS9: A Performance Overview of Merck’s Virology and Immunology Drugs.NEWS10: Drug distributor Cardinal's profit beats on pharma unit strength.

Answer: Decrease